Bioprocessing Application Notes & Case Studies

  1. Intact- And Peptide-Level Characterization Of T-DM1 In Vitro 6/18/2026

    A sensitive workflow that combines affinity capture and high-resolution mass spectrometry reveals how antibody-drug conjugates evolve under physiological conditions, offering deeper insight into their stability.

  2. Identification Of Conjugation Sites In An Antibody Drug Conjugate 6/18/2026

    A streamlined workflow enables confident mapping of lysine-linked conjugation sites in ADCs. See how integrated automation and high-resolution analysis simplify complex characterization challenges.

  3. Best Practices For Protein Analysis With An Analyzer System 6/18/2026

    Strong protein analysis relies on optimized preparation, buffer consistency, and precise method settings. Gain insight into how small changes in temperature, storage, or injection can impact accuracy.

  4. Comparing Two CE-SDS Systems Using NISTmAb 6/18/2026

    Fluorescence and UV detection deliver highly comparable results in protein capillary electrophoresis. See how both approaches perform across systems and what it means for protein analysis.

  5. Accurate mAb Sizing Using The NIST mAb As A Ladder 6/18/2026

    Improve your mAb sizing accuracy by integrating a well-characterized reference standard into your analysis workflows, which reduces variability and delivers more precise measurements.

  6. Scalable rAAV9 Production Using Advanced Cell Lines And Bioreactors 6/15/2026

    Progress in gene therapy manufacturing is being driven by improved cell line performance and scalable bioprocessing. See how high-density growth helps streamline development to larger-scale production.

  7. Develop Clones In Just 9 Weeks From Transfection With Up To 4X Titer 6/15/2026

    Transposon-based cell line development cuts timelines by 10 weeks and hits titers of 4.8 g/L in 17 days. See how SynWeave delivers measurable biologics manufacturing gains.

  8. 3X Bispecific Antibody Output, 98.5% Purity In 7 Months 6/15/2026

    Producing bispecific antibodies at scale is notoriously difficult. See how Syngene achieved a 3X yield increase and 98.5% purity for Hinge Bio's GEM-DIMER™ platform in just seven months.

  9. Direct Scale Up From Clone To 2K GMP Batches 6/15/2026

    N-1 perfusion technology increased antibody titers 1.5–4.5x over conventional fed-batch methods. See how high seed density and media blending cut costs and maximize suite utilization.

  10. Leveraging Integrated Media Services For Speed And Efficiency 6/12/2026

    Uncertainty in media stability can limit efficiency and scalability in biologics manufacturing. See how a data-driven approach enables more predictable planning and reduces operational strain.